A blood-based epigenetic test for colon cancer has been launched in Europe ... The test is the first epigenetic diagnostic to be sold as a kit to laboratories; other epigenetic-based tests ...
The kit, a fecal immunochemical test (FIT), uses antibodies to detect blood in stool. This blood is an early warning sign of colon cancer, and those who test positive are urged to undergo a ...
Colonoscopies are considered the gold standard for detecting colorectal cancer ... FDA last year approved at-home blood and stool tests for the disease, but are they a match for colonoscopies?
FDA recently approved the first blood test for colon cancer screening in adults ages 45 and older at average risk for the disease ... and at home the kit may get lost or forgotten.
This test predicts cancer recurrence, helping to guide clinical decisions after surgery or chemotherapy. Also Read: FDA Clears Exact Sciences’ Next-Generation Colorectal Cancer Diagnostic Test ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果